Investigation of the impact of birth by cesarean section on fetal and maternal metabolism

Arch Gynecol Obstet. 2019 Sep;300(3):589-600. doi: 10.1007/s00404-019-05213-w. Epub 2019 Jun 14.

Abstract

Purpose: Elective cesarean section (CS) was related to long-term adverse health effects in the offspring, but little is known about underlying mechanisms. Our study investigates the metabolic changes in both maternal and cord blood associated with CS in comparison to vaginal delivery (VD) to explore potential causal pathways.

Methods: Samples obtained from PREOBE study participants were subjected to LC-MS/MS-targeted metabolomics comprising > 200 metabolites.

Results: Elective CS showed an impact on both maternal and cord blood metabolomes. In maternal blood, the CS group showed lower levels of phospholipids (PL), principally ether-linked phosphatidylcholines (aaPC), pyruvic acid, branched chain keto-acids (BCKA), and other gluconeogenic substrates, but since the CS group showed different HDL levels in comparison to the VD group, we could not exclude contribution of the latter in the findings. In cord blood, the most remarkable finding in the CS group was the high levels of Cys; conversely, the lower levels of non-esterified fatty acids (NEFA), some tricarboxylic acid (TCA) cycle metabolites, gluconeogenic substrates, markers of β-oxidation, and the sum of hexoses were lower in CS-born babies in addition to tendentially lower levels of PL.

Conclusions: We speculate that lower levels of maternal and fetal corticosteroids in CS, due to less stressful condition, cause metabolic perturbations at birth initiating future negative health outcomes. This further supports the early programming hypothesis.

Keywords: Cord blood; Metabolic adaptation; Metabolomics; Mode of delivery; Stress hormones.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cesarean Section / adverse effects*
  • Cesarean Section / statistics & numerical data
  • Chromatography, Liquid
  • Delivery, Obstetric / methods
  • Delivery, Obstetric / statistics & numerical data*
  • Fatty Acids, Nonesterified / blood
  • Fatty Acids, Nonesterified / metabolism
  • Female
  • Fetal Blood / metabolism*
  • Fetus / blood supply*
  • Humans
  • Lipoproteins / blood*
  • Lipoproteins, HDL / blood
  • Metabolomics*
  • Parturition
  • Phospholipids / blood
  • Pregnancy
  • Prenatal Care
  • Spain
  • Tandem Mass Spectrometry

Substances

  • Fatty Acids, Nonesterified
  • Lipoproteins
  • Lipoproteins, HDL
  • Phospholipids